The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Terpenes in Treatment of Ovarian Cancer
|
|
Author(s): Emine İncilay Torunoğlu (Necmettin Erbakan University, Turkey), Gamze Demirel (Selçuk University, Turkey), Erdi Can Aytar (Usak University, Turkey)and Bahattin Avcı (Ondokuz Mayıs University, Turkey)
Copyright: 2025
Pages: 42
Source title:
Analyzing Terpenes' Role in Cancer Treatment
Source Author(s)/Editor(s): Bhawna Chopra (Guru Gobind Singh College of Pharmacy, India), Ashwani Kumar Dhingra (Global Research Institute of Pharmacy, India), Priyanka Kriplani (Guru Gobind Singh College of Pharmacy, India)and Ritu Ojha (Cathay General Hospital, Taiwan)
DOI: 10.4018/979-8-3693-6972-2.ch007
Purchase
|
Abstract
Ovarian cancer is the deadliest among gynecological cancers, with a high mortality rate due to late-stage diagnosis and inconspicuous early symptoms. A family history significantly increases the risk of ovarian cancer. Despite advances in treatment, survival rates remain low. Plants are valuable sources of various phytochemicals such as terpenes, carotenoids, and saponins, known for their antioxidant and antitumor properties. Terpenes like perillyl alcohol induce apoptosis in tumor cells, while compounds like oridonin, baicalein, and quercetin inhibit cancer cell growth and enhance the effectiveness of chemotherapy. These natural compounds are being explored as alternative or adjunctive treatments for ovarian cancer, with future research needed to optimize their therapeutic potential.
Related Content
|
Yiannis Koumpouros.
© 2026.
36 pages.
|
|
Antonios Archontis, Yiannis Koumpouros.
© 2026.
48 pages.
|
|
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy.
© 2026.
24 pages.
|
|
S. Ida Evangeline.
© 2026.
20 pages.
|
|
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana.
© 2026.
36 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
|